Carlos Camps1, Vega Iranzo, Roy M Bremnes, Rafael Sirera. 1. Servicio de Oncología Médica, Consorcio Hospital General Universitario de Valencia, Av. Tres Cruces s/n, 46014, Valencia, Spain. camps_car@gva.es
Abstract
INTRODUCTION: Malnutrition is a common problem in cancer patients. Its incidence varies according to disease stage (between 15 and 90%) and is considered a possible prognostic factor for therapeutic response and survival. It is also one of the causes contributing to the increase in morbidity and mortality in patients. Tumor cachexia is defined as a nutritional defect caused by tumor growth in the patient and presents as a significant weight loss. This weight loss is mainly caused by a degradation of skeletal muscle proteins. CONCLUSION: The ubiquitin-proteasome system is the most important pathway of protein degradation. As a regulatory system governing protein half-life, it is involved in the regulation of the cell cycle, signal transmission, immune system response, apoptosis, and oncogenesis. Knowledge of the molecular pathways involved in the induction of cancer-associated cachexia will favor a more rational approach to its treatment as well as possible quality of life and survival benefit for the patient.
INTRODUCTION: Malnutrition is a common problem in cancerpatients. Its incidence varies according to disease stage (between 15 and 90%) and is considered a possible prognostic factor for therapeutic response and survival. It is also one of the causes contributing to the increase in morbidity and mortality in patients. Tumor cachexia is defined as a nutritional defect caused by tumor growth in the patient and presents as a significant weight loss. This weight loss is mainly caused by a degradation of skeletal muscle proteins. CONCLUSION: The ubiquitin-proteasome system is the most important pathway of protein degradation. As a regulatory system governing protein half-life, it is involved in the regulation of the cell cycle, signal transmission, immune system response, apoptosis, and oncogenesis. Knowledge of the molecular pathways involved in the induction of cancer-associated cachexia will favor a more rational approach to its treatment as well as possible quality of life and survival benefit for the patient.
Authors: M Bossola; M Muscaritoli; P Costelli; R Bellantone; F Pacelli; S Busquets; J Argilès; F J Lopez-Soriano; I M Civello; F M Baccino; F Rossi Fanelli; G B Doglietto Journal: Am J Physiol Regul Integr Comp Physiol Date: 2001-05 Impact factor: 3.619
Authors: Z H Khan; E J Simpson; A T Cole; M Holt; I MacDonald; D Pye; A Austin; J G Freeman Journal: Aliment Pharmacol Ther Date: 2003-03-01 Impact factor: 8.171
Authors: W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey Journal: Am J Med Date: 1980-10 Impact factor: 4.965
Authors: Camila Oliveira de Souza; Mirian Ayumi Kurauti; Flaviane de Fatima Silva; Hely de Morais; Glaucia Regina Borba-Murad; Fábio Goulart de Andrade; Helenir Medri de Souza Journal: Mol Cell Biochem Date: 2014-10-31 Impact factor: 3.396
Authors: Jeannine Bachmann; Knut Ketterer; Christiane Marsch; Kerstin Fechtner; Holger Krakowski-Roosen; Markus W Büchler; Helmut Friess; Marc E Martignoni Journal: BMC Cancer Date: 2009-07-28 Impact factor: 4.430
Authors: Jeffrey S Damrauer; Michael E Stadler; Swarnali Acharyya; Albert S Baldwin; Marion E Couch; Denis C Guttridge Journal: Eur J Transl Myol Date: 2018-06-06